INVO Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on April 14, 2017, by INVO Bioscience, Inc. (Nevada). The filing addresses significant delays in the company's regulatory reporting obligations and clarifies a dispute regarding asset ownership involving a former officer.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on compliance status and legal matters rather than financial performance data.
Material Changes and Reporting Delays
- 10-K Delay: The 2016 Annual Report (Form 10-K) will not be filed by the extended deadline of April 17, 2017. The company cites unexpected, time-consuming events and limited resources as causes.
- New Filing Target: The company expects to file the 2016 Form 10-K by April 24, 2017.
- Outstanding Quarterly Reports: The company is not current in its reporting requirements. It has not filed Form 10-Qs for the quarters ended March 31, 2016, June 30, 2016, or September 30, 2016.
- 10-Q Filing Target: The company expects to file the missing 10-Qs by May 15, 2017.
Legal Matters and Management Commentary
The company responded to a letter from the attorney of Claude Ranoux (a former officer/director) regarding the return of company property. Ranoux's attorney agreed to return INVO-owned property but requested documentation proving INVO's ownership of assets originally owned by Medelle.
Management clarified that INVO Bioscience, through its wholly owned subsidiary BioXcell, owns all of Medelle's former assets, including patents. The company stated that Dr. Ranoux purchased Medelle's assets and transferred them to INVO Bioscience upon its formation in 2007, a fact previously referenced in signed Form 10-K annual reports.
Key Facts for Investor Verification
- Verify the actual filing date of the 2016 Form 10-K against the April 24, 2017 target.
- Confirm the submission of the three missing Form 10-Qs (Q1, Q2, Q3 2016) by the May 15, 2017 deadline.
- Monitor the status of the dispute with Claude Ranoux regarding the return of physical assets and intellectual property.
- Review the upcoming 10-K for details on the "unexpected and time consuming events" cited as the cause for the reporting delays.